Cardiac stent patients with diabetes may benefit from drug that counteracts the effects of leptin

Thursday, December 18, 2008 - 07:15 in Health & Medicine

The naturally high levels of leptin in diabetic patients may reduce the effectiveness of drug-eluting stents used to treat heart blockages, but using a chemical that differs from the one commonly used to coat stents could counteract this effect...

Read the whole article on Science Centric

More from Science Centric

Related

Latest Science Newsletter

Get the latest and most popular science news articles of the week in your Inbox!